There have been 50 recent insider transactions recorded for Zosano Pharma Corporation (ZSAN), including 38 buys and 11 sells. Total insider buying was valued at $5.29M and total insider selling at $38.93K.
Notable insiders with recent activity include Lo Steven, Matthews Christine, Kellerman Donald J. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ZSAN
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2022-06-06 |
Lo Steven |
Chief Executive Officer |
Informative Sell |
442 |
$0.71 |
$313.82 |
13,163 |
| 2022-06-06 |
Matthews Christine |
Chief Financial Officer |
Informative Sell |
82 |
$0.71 |
$58.22 |
4,183 |
| 2022-03-31 |
Kellerman Donald J |
VP, Clinical Dev & Med Affairs |
Informative Sell |
4,006 |
$0.21 |
$841.66 |
56,331 |
| 2022-03-31 |
Lo Steven |
Chief Executive Officer |
Informative Sell |
23,633 |
$0.21 |
$4.97K |
460,709 |
| 2022-03-31 |
Matthews Christine |
Chief Financial Officer |
Informative Sell |
8,116 |
$0.21 |
$1.71K |
146,425 |
| 2021-11-23 |
Greathouse Kenneth |
Director |
Informative Sell |
10,000 |
$0.60 |
$6.02K |
43,500 |
| 2021-10-15 |
Kellerman Donald J |
VP, Clinical Dev & Med Affairs |
RSU Award |
20,000 |
$0.63 |
$12.68K |
20,000 |
| 2021-10-15 |
Lo Steven |
Chief Executive Officer |
RSU Award |
237,500 |
$0.63 |
$150.62K |
237,500 |
| 2021-10-15 |
Matthews Christine |
Chief Financial Officer |
RSU Award |
112,500 |
$0.63 |
$71.35K |
112,500 |
| 2021-06-10 |
Greathouse Kenneth |
Director |
RSU Award |
30,000 |
$0.93 |
$27.95K |
30,000 |
| 2021-06-10 |
Elms Steve |
Director |
RSU Award |
15,000 |
- |
- |
22,500 |
| 2021-06-10 |
Xanthopoulos Kleanthis G |
Director |
RSU Award |
15,000 |
- |
- |
23,596 |
| 2021-06-10 |
Hagan Joseph P |
Director |
RSU Award |
15,000 |
- |
- |
22,500 |
| 2021-06-04 |
Kellerman Donald J |
VP, Clinical Dev & Med Affairs |
Informative Sell |
1,709 |
$0.81 |
$1.38K |
50,337 |
| 2021-06-04 |
Lo Steven |
Chief Executive Officer |
Informative Sell |
13,158 |
$0.81 |
$10.59K |
365,592 |
| 2021-06-04 |
Lewis Hayley |
See Remarks |
Informative Sell |
1,709 |
$0.81 |
$1.38K |
49,779 |
| 2021-06-04 |
Matthews Christine |
Chief Financial Officer |
Informative Sell |
1,709 |
$0.81 |
$1.38K |
98,291 |
| 2021-05-17 |
Greathouse Kenneth |
Director |
RSU Award |
21,000 |
$0.73 |
$15.31K |
38,500 |
| 2021-03-30 |
Kellerman Donald J |
VP, Clinical Dev & Med Affairs |
RSU Award |
32,500 |
- |
- |
52,046 |
| 2021-03-30 |
Lo Steven |
Chief Executive Officer |
RSU Award |
232,500 |
- |
- |
378,750 |
| 2021-03-30 |
Lewis Hayley |
See Remarks |
RSU Award |
32,500 |
- |
- |
51,488 |
| 2021-03-30 |
Matthews Christine |
Chief Financial Officer |
RSU Award |
81,250 |
- |
- |
100,000 |
| 2021-03-18 |
Lo Steven |
Chief Executive Officer |
RSU Award |
450,000 |
$1.37 |
$616.5K |
450,000 |
| 2020-06-25 |
Kellerman Donald J |
VP, Clinical Dev & Med Affairs |
RSU Award |
18,750 |
- |
- |
19,546 |
| 2020-06-25 |
Greathouse Kenneth |
Director |
RSU Award |
7,500 |
- |
- |
17,500 |
| 2020-06-25 |
Walker John Peter |
Director |
RSU Award |
7,500 |
- |
- |
116,511 |
| 2020-06-25 |
Elms Steve |
Director |
RSU Award |
7,500 |
- |
- |
7,500 |
| 2020-06-25 |
Xanthopoulos Kleanthis G |
Director |
RSU Award |
7,500 |
- |
- |
8,596 |
| 2020-06-25 |
Hagan Joseph P |
Director |
RSU Award |
7,500 |
- |
- |
7,500 |
| 2020-06-25 |
Lo Steven |
Chief Executive Officer |
RSU Award |
146,250 |
- |
- |
146,250 |
| 2020-06-25 |
Lewis Hayley |
See Remarks |
RSU Award |
18,750 |
- |
- |
18,988 |
| 2020-06-25 |
Matthews Christine |
Chief Financial Officer |
RSU Award |
18,750 |
- |
- |
18,750 |
| 2020-06-03 |
Kellerman Donald J |
VP, Clinical Dev & Med Affairs |
RSU Award |
37,500 |
$1.01 |
$37.88K |
37,500 |
| 2020-06-03 |
Greathouse Kenneth |
Director |
RSU Award |
15,000 |
$1.01 |
$15.15K |
15,000 |
| 2020-06-03 |
Walker John Peter |
Director |
RSU Award |
15,000 |
$1.01 |
$15.15K |
15,000 |
| 2020-06-03 |
Elms Steve |
Director |
RSU Award |
15,000 |
$1.01 |
$15.15K |
15,000 |
| 2020-06-03 |
Xanthopoulos Kleanthis G |
Director |
RSU Award |
15,000 |
$1.01 |
$15.15K |
15,000 |
| 2020-06-03 |
Hagan Joseph P |
Director |
RSU Award |
15,000 |
$1.01 |
$15.15K |
15,000 |
| 2020-06-03 |
Lo Steven |
Chief Executive Officer |
RSU Award |
292,500 |
$1.01 |
$295.43K |
292,500 |
| 2020-06-03 |
Lewis Hayley |
See Remarks |
RSU Award |
37,500 |
$1.01 |
$37.88K |
37,500 |
| 2020-06-03 |
Matthews Christine |
Chief Financial Officer |
RSU Award |
37,500 |
$1.01 |
$37.88K |
37,500 |
| 2020-05-01 |
Matthews Christine |
Chief Financial Officer |
RSU Award |
35,000 |
$0.70 |
$24.54K |
35,000 |
| 2020-02-03 |
Matthews Christine |
See Remarks |
Disposition |
3,750 |
$2.75 |
$10.31K |
- |
| 2019-12-02 |
Aisling Capital Iv, Lp |
10 Percent Owner |
RSU Award |
689,655 |
$1.45 |
$1000K |
2,718,226 |
| 2019-10-21 |
Lo Steven |
Chief Executive Officer |
Unknown |
- |
- |
- |
- |
| 2019-10-21 |
Lo Steven |
Chief Executive Officer |
RSU Award |
450,000 |
$1.94 |
$873K |
450,000 |
| 2019-06-11 |
Kellerman Donald J |
VP, Clinical Dev & Med Affairs |
RSU Award |
30,000 |
$2.75 |
$82.5K |
30,000 |
| 2019-06-11 |
Lewis Hayley |
See Remarks |
RSU Award |
30,000 |
$2.75 |
$82.5K |
30,000 |
| 2019-04-11 |
Aisling Capital Iv, Lp |
10 Percent Owner |
RSU Award |
428,571 |
$3.50 |
$1.5M |
2,028,571 |
| 2019-04-11 |
Walker John Peter |
President & CEO |
Informative Buy |
100,000 |
$3.50 |
$350K |
280,228 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry